OrthoPediatrics Corp at Needham Healthcare Conference (Virtual) Transcript
Good morning. Thanks for joining us at the 22nd Annual Needham Healthcare Conference. I'm Mike Matson and I lead the medtech and diagnostics equity research team here at Needham & Company.
I'm pleased to introduce OrthoPediatrics. Presenting from the company, we have President and CEO, David Bailey; and CFO, Fred Hite. Instead of a standard presentation, we're going to do a Q&A session. (Conference Instructions) And so with that, we're going to start with the Q&A.
Questions & Answers
So I guess I'm going to start with the fourth quarter, you saw a significant headwind from increased respiratory illnesses in children, COVID, but also RSV and the flu. Can you just kind of recap what happened, what you were seeing, and maybe give us an update if possible on what you've seen since then? Have the headwinds eased or did they continue to spill into the first quarter?
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |